Atellica CH Gamma-Glutamyl Transferase-IIn vitro diagnostic use in the quantitative determination of gamma-glutamyl transferase in human serum and plasma (lithium heparin Test Code: GGT Siemens Material Number (SMN): 11097597
Published September 6, 2023 · Recall initiated: July 10, 2023
Summary
FDA records medical device Class II recall Z-2473-2023, published September 6, 2023 and initiated July 10, 2023. Recalling firm: Siemens Healthcare Diagnostics, Inc.; Status: Ongoing; Reported quantity: 19544 units; Lot: Unique Device Identification (UDI): 00630414596440 All Lot Numbers. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Potential for reagent carryover on the Atellica CH 930 resulting in a positive bias that could impact quality control (QC), patient samples, and calibrator results with from Atellica®CH Total Bilirubin_2 (TBil_2), Atellica® CH LDL Cholesterol (LDLC), Atellica® CH Gamma-Glutamyl Transferase (GGT) and Atellica® CH HDL Cholesterol (HDLC)
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Siemens Healthcare Diagnostics, Inc.
- Distributor
- US Nationwide - Worldwide Distribution Foreign: Taiwan Uruguay Vietnam
- Lot
- Unique Device Identification (UDI): 00630414596440 All Lot Numbers
- Risk classification
- Class II
- Area (FDA)
- device
- Country
- United States
Related recalls
- FDAAtellica CH Revised C-Reactive Protein (RCRP); Siemens Material Number (SMN): 11537223;October 7, 2026
- FDABeckman Coulter, Emit 2000 Quinidine Assay REF: OSR4Q229 Contents: R1: 2 x 23 mL;R2 2x13 mLAugust 26, 2026
- FDASyva EMIT 2000 Quinidine Assay REF: 4Q019UL Contents: 1x28 mL, 1x14mLAugust 26, 2026
- FDASyva Emit tox Serum Tricyclic Antidepressant Calibrator/Controls SMN 10445390 Catalog No. 7C219ULAugust 12, 2026
- FDAAtellica CH Triglycerides (concentrated)-In vitro diagnostic use in the quantitative measurement ofSeptember 6, 2023
- FDAOculus Pentacam AXL , Ref 70100, CE 0123September 6, 2023
Questions about this recall
Was Atellica CH Gamma-Glutamyl Transferase-IIn vitro diagnostic use in the quantitative determination of gamma-glutamyl transferase in human serum and plasma (lithium heparin Test Code: GGT Siemens Material Number (SMN): 11097597 recalled?
Yes. FDA published recall Z-2473-2023 on September 6, 2023. Reported hazard: Potential for reagent carryover on the Atellica CH 930 resulting in a positive bias that could impact quality control (QC), patient samples, and calibrator results with from Atellica®CH Total Bilirubin_2 (TBil_2), Atellica® CH LDL Cholesterol (LDLC), Atellica® CH Gamma-Glutamyl Transferase (GGT) and Atellica® CH HDL Cholesterol (HDLC)
What should I do if I have this product?
Voluntary: Firm initiated · Letter